Too bad that HemaXellerate is ENTIRELY SAFE!!!!!!!!!!! ROFLMAO
IN DRUGS WITH SAFETY ISSUES 3 ROUNDS IS COMMON! ROFLMAO THE DRUG BMSN IS DEVELOPING USES THE PATIENTS OWN CELLS, OWN BLOOD, COMPLETELY AND SPECIFICALLY TAILORED TO EVERY INDIVIDUAL SO NO RISK OF HARM OR DANGER OR REJECTION!!!!!!!!! WOWWWWWWWW!!!!!!!! ROFLMAO
HemaXellerate is that first drug in the Bio Matrix Scientific Group - the proverbial guinea pig. And, it's already hit growing pains as well as celebration-worthy milestones, which are largely reflected in the stock's chart. The surge in January stemmed from the company's filing of the IND for HemaXellerate, and the pullback a few weeks later was the result the FDA asking questions about the proposed clinical trial plans rather than simply giving BMSN the green light to proceed. [Questions imply there's something the Food and Drug Administration is concerned about.]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.